The Opportunity With tens of millions of Americans expected to adopt GLP-1 therapies in the coming years, demand will rise for tools that help users navigate side effects, maintain muscle mass, and establish sustainable eating patterns
5 Scratch-injury has already been reported as an essential step in keratinocyte migration
A standard research dose (e.g., 100mcg) might produce a mild, barely noticeable flush
Most importantly, its a poor experience for the growing numbers who deserve thoughtful care with GLP-1 weight loss results they can trust
Lillys tirzepatide delivered up to 22.5% weight loss in adults with obesity or overweight in SURMOUNT-1, Eli Lilly (2022) There are upcoming changes to your plans drug coverage and we want to be sure youre ready, Aetna (2025) Pharmacy clinical policy bulletins Aetna non-Medicare prescription drug plan, Aetna (2024) Aetna Better Health coverage policy guideline, Aetna (2025) Medicine search tool, Aetna (2025) FDA approves new medication for chronic weight management, U.S
